The material on this site is for financial institutions, professional investors and their professional advisers. It is for information only. Please read our Terms & Conditions, Privacy Policy and Cookies before using this site.

All material subject to strictly enforced copyright laws. © 2020 Euromoney, a part of the Euromoney Institutional Investor PLC.

Technology Banking: Morgan Stanley's head start

When Frank Quattrone left Morgan Stanley in 1996, nearly everyone thought Morgan's technology franchise would go with him. But the Wall Street firm's edge in California wasn't blunted. Quattrone's magic has now faded, and all competitors bar one seem to be floundering. Michelle Celarier reports

The day after Morgan Stanley Dean Witter started the roadshow for Healtheon - its fifth internet initial public offering of the year - the leading global investment bank in technology investment banking suddenly pulled the plug. Although the firm says it had commitments from enough institutional investors to go forward, the markets suddenly nose-dived on the news that Long-Term Capital Management was sinking. Internet IPOs are blatantly speculative, and Healtheon's aftermarket performance in early October was difficult to predict. So Rex Golding, Morgan's co-head of the global technology group, advised a private placement instead.

"We hit terrible market conditions," says Golding, who had been worrying about the environment for IPOs ever since the summer slowdown, when scores were pulled, and August 31 when there was a sell-off of even big-cap tech stocks such as Microsoft, Intel and Cisco.

Take out a complimentary trial

Take out a 7 day trial to gain unlimited access to and analysis and receive expertly-curated updates direct to your inbox.


Already a user?

Login now


We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree